Article
Treatment of genetic defects of thiamine transport and metabolism.
Expert review of neurotherapeutics - 1 Jul 2016
Ortigoza-Escobar Juan Darío, Molero-Luis Marta, Arias Angela, Martí-Sánchez Laura, Rodriguez-Pombo Pilar, Artuch Rafael, Pérez-Dueñas Belén
Abstract excerpt
INTRODUCTION: Thiamine is a key cofactor for energy metabolism in brain tissue. There are four major genetic defects (SLC19A2, SLC19A3, SLC25A19 and TPK1) involved in the metabolism and transport of thiamine through cellular and mitochondrial membranes. Neurological involvement predominates in three of them (SLC19A3, SCL25A19 and TPK1), whereas patients with SLC19A2 mutations mainly present extra-neurological...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
